12 Paul Tudor Jones II BridgeBio Pharma Trades
The first BridgeBio Pharma trade was made in Q2 2021. Since then Paul Tudor Jones II bought shares five more times and sold shares on six occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in BridgeBio Pharma anymore.
Avg closing price
Price range
Sold -22.2 Thousand shares
Q2 2024
Avg closing price
$27.34
Price range
$23.00
-
$31.04
New holding (+22.2 Thousand shares)
Q1 2024
Avg closing price
$34.01
Price range
$27.35
-
$40.45
Sold -81.2 Thousand shares
Q4 2023
Avg closing price
$30.03
Price range
$24.02
-
$43.89
New holding (+81.2 Thousand shares)
Q3 2023
Avg closing price
$28.38
Price range
$16.89
-
$35.01
Sold -23.3 Thousand shares
Q2 2023
Avg closing price
$15.05
Price range
$13.29
-
$18.01
Sold 68.7% shares (-51.2 Thousand shares)
Q1 2023
Avg closing price
$11.66
Price range
$7.17
-
$18.55
Sold 6.5% shares (-5.22 Thousand shares)
Q4 2022
Avg closing price
$9.57
Price range
$6.74
-
$11.52
New holding (+79.7 Thousand shares)
Q3 2022
Avg closing price
$10.39
Price range
$7.94
-
$12.36
Sold -120 Thousand shares
Q1 2022
Avg closing price
$10.26
Price range
$7.34
-
$17.16
Increased shares by 32.7% (+29.7 Thousand shares)
Q4 2021
Avg closing price
$42.31
Price range
$11.38
-
$53.41
Increased shares by 92.7% (+43.6 Thousand shares)
Q3 2021
Avg closing price
$53.60
Price range
$46.87
-
$64.24
New holding (+47.1 Thousand shares)
Q2 2021
Avg closing price
$57.11
Price range
$46.47
-
$63.93
